These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 2127807

  • 21. Positron emission tomography with 4-[18F]fluoro-L-m-tyrosine in MPTP-induced hemiparkinsonian monkeys.
    Hayase N, Tomiyoshi K, Watanabe K, Horikoshi S, Shibasaki T, Ohye C.
    Ann Nucl Med; 1995 Aug; 9(3):119-23. PubMed ID: 8534583
    [Abstract] [Full Text] [Related]

  • 22. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced acute transient dystonia in monkeys associated with low striatal dopamine.
    Tabbal SD, Mink JW, Antenor JA, Carl JL, Moerlein SM, Perlmutter JS.
    Neuroscience; 2006 Sep 01; 141(3):1281-7. PubMed ID: 16766129
    [Abstract] [Full Text] [Related]

  • 23. Human striatal L-dopa decarboxylase activity estimated in vivo using 6-[18F]fluoro-dopa and positron emission tomography: error analysis and application to normal subjects.
    Kuwabara H, Cumming P, Reith J, Léger G, Diksic M, Evans AC, Gjedde A.
    J Cereb Blood Flow Metab; 1993 Jan 01; 13(1):43-56. PubMed ID: 8417009
    [Abstract] [Full Text] [Related]

  • 24. Combined FDOPA and 3OMFD PET studies in Parkinson's disease.
    Dhawan V, Ishikawa T, Patlak C, Chaly T, Robeson W, Belakhlef A, Margouleff C, Mandel F, Eidelberg D.
    J Nucl Med; 1996 Feb 01; 37(2):209-16. PubMed ID: 8667046
    [Abstract] [Full Text] [Related]

  • 25. 6-[18F]fluoro-L-dopa uptake and [76Br]bromolisuride binding in the excitotoxically lesioned caudate-putamen of nonhuman primates studied using positron emission tomography.
    Hantraye P, Loc'H C, Maziere B, Khalili-Varasteh M, Crouzel C, Fournier D, Yorke JC, Stulzaft O, Riche D, Isacson O.
    Exp Neurol; 1992 Feb 01; 115(2):218-27. PubMed ID: 1531196
    [Abstract] [Full Text] [Related]

  • 26. 6-[18F]fluoro-L-m-tyrosine: metabolism, positron emission tomography kinetics, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lesions in primates.
    Jordan S, Eberling JL, Bankiewicz KS, Rosenberg D, Coxson PG, VanBrocklin HF, O'Neil JP, Emborg ME, Jagust WJ.
    Brain Res; 1997 Mar 07; 750(1-2):264-76. PubMed ID: 9098552
    [Abstract] [Full Text] [Related]

  • 27. Positron emission tomography with 18F-dopa: interpretation and biological correlates in nonhuman primates.
    Doudet DJ, Aigner TG, McLellan CA, Cohen RM.
    Psychiatry Res; 1992 Nov 07; 45(3):153-68. PubMed ID: 1283014
    [Abstract] [Full Text] [Related]

  • 28. On the accuracy of an [18F]FDOPA compartmental model: evidence for vesicular storage of [18F]fluorodopamine in vivo.
    Deep P, Gjedde A, Cumming P.
    J Neurosci Methods; 1997 Oct 03; 76(2):157-65. PubMed ID: 9350967
    [Abstract] [Full Text] [Related]

  • 29. Comparative in vivo metabolism of 6-[18F]fluoro-L-dopa and [3H]L-dopa in rats.
    Melega WP, Luxen A, Perlmutter MM, Nissenson CH, Phelps ME, Barrio JR.
    Biochem Pharmacol; 1990 Jun 15; 39(12):1853-60. PubMed ID: 2112915
    [Abstract] [Full Text] [Related]

  • 30. Cerebral 6-[(18)F]fluoro-L-DOPA (FDOPA) metabolism in pig studied by positron emission tomography.
    Danielsen EH, Smith DF, Gee AD, Venkatachalam TK, Hansen SB, Hermansen F, Gjedde A, Cumming P.
    Synapse; 1999 Sep 15; 33(4):247-58. PubMed ID: 10421705
    [Abstract] [Full Text] [Related]

  • 31. Asymptomatic striatal dopamine depletion: PET scans in unilateral MPTP monkeys.
    Guttman M, Yong VW, Kim SU, Calne DB, Martin WR, Adam MJ, Ruth TJ.
    Synapse; 1988 Sep 15; 2(5):469-73. PubMed ID: 3263709
    [Abstract] [Full Text] [Related]

  • 32. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
    Rioux L, Frohna PA, Joyce JN, Schneider JS.
    Mov Disord; 1997 Mar 15; 12(2):148-58. PubMed ID: 9087972
    [Abstract] [Full Text] [Related]

  • 33. Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants.
    Sawle GV, Bloomfield PM, Björklund A, Brooks DJ, Brundin P, Leenders KL, Lindvall O, Marsden CD, Rehncrona S, Widner H.
    Ann Neurol; 1992 Feb 15; 31(2):166-73. PubMed ID: 1575455
    [Abstract] [Full Text] [Related]

  • 34. Loss of metabolites from monkey striatum during PET with FDOPA.
    Cumming P, Munk OL, Doudet D.
    Synapse; 2001 Sep 01; 41(3):212-8. PubMed ID: 11391782
    [Abstract] [Full Text] [Related]

  • 35.
    Leung K.
    ; 2004 Sep 01. PubMed ID: 20641250
    [Abstract] [Full Text] [Related]

  • 36. Polymer-encapsulated PC-12 cells demonstrate high-affinity uptake of dopamine in vitro and 18F-Dopa uptake and metabolism after intracerebral implantation in nonhuman primates.
    Subramanian T, Emerich DF, Bakay RA, Hoffman JM, Goodman MM, Shoup TM, Miller GW, Levey AI, Hubert GW, Batchelor S, Winn SR, Saydoff JA, Watts RL.
    Cell Transplant; 1997 Sep 01; 6(5):469-77. PubMed ID: 9331498
    [Abstract] [Full Text] [Related]

  • 37. Tremor is associated with PET measures of nigrostriatal dopamine function in MPTP-lesioned monkeys.
    Eberling JL, Pivirotto P, Bringas J, Bankiewicz KS.
    Exp Neurol; 2000 Oct 01; 165(2):342-6. PubMed ID: 10993693
    [Abstract] [Full Text] [Related]

  • 38. A kinetic analysis of 6-[18F]fluoro-L-dihydroxyphenylalanine metabolism in the rat.
    Cumming P, Kuwabara H, Gjedde A.
    J Neurochem; 1994 Nov 01; 63(5):1675-82. PubMed ID: 7931323
    [Abstract] [Full Text] [Related]

  • 39. Metabolites of 6-[18F]fluoro-L-dopa in human blood.
    Firnau G, Sood S, Chirakal R, Nahmias C, Garnett ES.
    J Nucl Med; 1988 Mar 01; 29(3):363-9. PubMed ID: 3126278
    [Abstract] [Full Text] [Related]

  • 40. [PET study using 6-[18F]-fluorodopa in Parkinson's disease].
    Nagasawa H, Tanji H, Itoh M, Itoyama Y.
    Nihon Rinsho; 1997 Jan 01; 55(1):213-7. PubMed ID: 9014452
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.